US FDA News: FDA statement on approval of OTC Primatene Mist to treat mild asthma

FDA approves new version of OTC Primatene Mist inhaler to treat mild, intermittent asthma for people who have been diagnosed with asthma by their physician
Read more: FDA statement on approval of OTC Primatene Mist to treat mild asthma